학술논문

Early Release - Zoster Meningitis in an Immunocompetent Child after COVID-19 Vaccination, California, USA - Volume 28, Number 7—July 2022 - Emerging Infectious Diseases journal - CDC
Document Type
article
Source
Emerging Infectious Diseases. 28(7)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Clinical Sciences
Prevention
Pediatric
Vaccine Related
Infectious Diseases
Immunization
3.4 Vaccines
Prevention of disease and conditions
and promotion of well-being
Infection
Good Health and Well Being
Adult
Aged
COVID-19
COVID-19 Vaccines
Chickenpox
Child
Herpes Zoster
Herpes Zoster Vaccine
Humans
Meningitis
Vaccination
COVID-19 vaccination
California
SARS-CoV-2
coronavirus disease
papulovesicular rash
respiratory infections
severe acute respiratory syndrome coronavirus 2
vaccine-preventable diseases
varicella zoster virus
viruses
zoonoses
zoster meningitis
Public Health and Health Services
Microbiology
Clinical sciences
Epidemiology
Health services and systems
Language
Abstract
Varicella zoster virus reactivation after COVID-19 vaccination has been reported in older or immunocompromised adults. We report zoster meningitis from live-attenuated varicella vaccine reactivation in an immunocompetent child after COVID-19 vaccination. This type of case is rare; COVID-19 and varicella vaccines remain safe and effective for appropriate recipients in the pediatric population.